Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (869) 869
Publication (137) 137
Book / eBook (26) 26
Book Chapter (11) 11
Patent (8) 8
Newsletter (4) 4
Web Resource (4) 4
Conference Proceeding (2) 2
Book Review (1) 1
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (356) 356
index medicus (264) 264
female (260) 260
male (242) 242
middle aged (234) 234
aged (222) 222
adult (205) 205
oncology (146) 146
hematology (140) 140
aged, 80 and over (134) 134
prognosis (90) 90
cancer (88) 88
article (85) 85
rituximab (72) 72
lymphomas (69) 69
risk factors (65) 65
treatment outcome (65) 65
young adult (62) 62
adolescent (58) 58
lymphoma (56) 56
disease-free survival (55) 55
chemotherapy (54) 54
research (54) 54
analysis (52) 52
antineoplastic combined chemotherapy protocols - therapeutic use (52) 52
non-hodgkins-lymphoma (51) 51
survival (46) 46
animals (45) 45
care and treatment (43) 43
neoplasm staging (43) 43
survival analysis (42) 42
expression (40) 40
lymphoma, large b-cell, diffuse - drug therapy (40) 40
retrospective studies (38) 38
surgery (38) 38
survival rate (38) 38
b-cell lymphoma (36) 36
hemic and lymphatic diseases (36) 36
abridged index medicus (35) 35
therapy (35) 35
antineoplastic agents - therapeutic use (33) 33
cell biology (33) 33
disease (33) 33
risk (33) 33
follow-up studies (31) 31
prospective studies (31) 31
cohort studies (30) 30
biochemistry & molecular biology (29) 29
genetic aspects (29) 29
non-hodgkin lymphoma (29) 29
case-control studies (26) 26
elderly-patients (26) 26
follicular lymphoma (26) 26
health aspects (26) 26
lymphoma, large b-cell, diffuse - mortality (26) 26
diagnosis (24) 24
medicine & public health (24) 24
medicine, general & internal (24) 24
time factors (24) 24
kaplan-meier estimate (23) 23
medical research (23) 23
multivariate analysis (23) 23
age factors (22) 22
cyclophosphamide - administration & dosage (22) 22
gene expression (22) 22
genetics & heredity (22) 22
lymphoma, large b-cell, diffuse - pathology (22) 22
patients (22) 22
united states (22) 22
antibodies, monoclonal - therapeutic use (21) 21
antibodies, monoclonal, murine-derived (21) 21
lymphoma, non-hodgkin - pathology (21) 21
mortality (21) 21
non-hodgkin-lymphoma (21) 21
recurrence (21) 21
antineoplastic combined chemotherapy protocols - administration & dosage (20) 20
doxorubicin - administration & dosage (20) 20
epidemiology (20) 20
genes (20) 20
non-hodgkin's lymphomas (20) 20
proteins (20) 20
vincristine - administration & dosage (20) 20
genomes (19) 19
genomics (19) 19
immune system diseases (19) 19
immunohistochemistry (19) 19
medicine, experimental (19) 19
association (18) 18
leukemia (18) 18
proportional hazards models (18) 18
tumors (18) 18
life sciences (17) 17
pathology (17) 17
polymorphism, single nucleotide (17) 17
prednisone - administration & dosage (17) 17
aneuploidy (16) 16
chemotherapy plus rituximab (16) 16
child (16) 16
chop (16) 16
cyclophosphamide (16) 16
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Online Resources - Online (4) 4
Robarts - Stacks (4) 4
Architecture Landscape (Shore + Moffat) - Stacks (3) 3
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (2) 2
UTL at Downsview - May be requested (2) 2
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Engineering & Comp. Sci. - Missing (1) 1
Engineering & Comp. Sci. - Stacks (1) 1
Gerstein Science - Stacks (1) 1
Robarts - Not Returned (1) 1
St. Michael's Hospital - Stacks (1) 1
Victoria University CRRS - Library use only (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Mayo Clinic internal medicine concise textbook
by Habermann, Thomas M and Ghosh, Amit and Mayo Clinic
2008, ISBN 1420067494, xiv, 914
Communicable Diseases | Internal Medicine | therapy
Book
Details down arrow
2. Mayo Clinic internal medicine review, 2006-2007
by Habermann, Thomas M and Mayo Clinic
2006, 7th ed., ISBN 9780849390593, xci, 1035
Internal Medicine
Book
Details down arrow
3. Full Text Maximizing FDG-PET/CT Utility in Staging of Follicular Lymphoma (FL): The Role of Spleen Involvement and Bone Standardized Uptake Values
by St-Pierre, Frederique and Broski, Stephen and Laplant, Betsy and Habermann, Thomas M and Witzig, Thomas E
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 2811 - 2811
Background: FDG PET/CT and bone marrow biopsy (BMB) are considered standard procedures for the staging of patients with new, untreated FL. A key issue in FL is... 
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Characteristics of Patients with Relapsed/Refractory Burkitt Non-Hodgkin Lymphoma (NHL): Impact on the Feasibility of CAR-T Cell Therapy
by Fortin Gamero, Sonia and Lin, Yi and Kenderian, Saad S and Bennani, N. Nora and Thanarajasingam, Gita and Habermann, Thomas M and Nowakowski, Grzegorz and Witzig, Thomas E
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 5352 - 5352
Background Burkitt NHL (BL) is a rare hematologic malignancy that occurs in younger adults and is highly curable with aggressive chemoimmunotherapy induction... 
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Clinical Features and Treatment for Neurolymphomatosis in the Rituximab Era: Single Institution Experience
by Novo, Mattia and Nowakowski, Grzegorz and Micallef, Ivana and King, Rebecca L and Spinner, Robert and Ristow, Kay M and Habermann, Thomas M and Johnston, Patrick
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 4129 - 4129
Background: Neurolymphomatosis (NL) is a highly rare disorder defined as infiltration of peripheral nervous system by a lymphoproliferative neoplasm, both... 
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Clinical Significance of Testicular FDG-PET/CT Uptake in Aggressive Lymphomas
by Kim, Hidong and Harper, Laura and Habermann, Thomas M and Nowakowski, Grzegorz S and Thompson, Carrie A and Johnston, Patrick and Witzig, Thomas E and Allmer, Cristine and Maurer, Matthew J and Cerhan, James R and Young, Jason and Thanarajasingam, Gita
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 5401 - 5401
Abstract Introduction Primary testicular lymphoma (PTL) and testicular involvement of systemic lymphoma (secondary testicular lymphoma, STL) are uncommon. Most... 
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Non-Diffuse Large B-Cell Primary Central Nervous System Lymphoma
by Gandhi, Sangeetha and Nowakowski, Grzegorz S and Habermann, Thomas M and Ristow, Kay M and Johnston, Patrick
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 4208 - 4208
Abstract Background: The majority of subjects with a diagnosis of primary central nervous system lymphoma (PCSNL) have diffuse large B-cell lymphoma (DLBCL) as... 
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Impact of Early Rasburicase on Incidence and Outcomes of Clinical Tumor Lysis Syndrome in Lymphoma
by Personett, Heather A and Barreto, Erin F and McCullough, Kristen and Dierkhising, Ross and Leung, Nelson and Habermann, Thomas M
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 1717 - 1717
Abstract Introduction: Clinical tumor lysis syndrome (TLS), which manifests most often as acute kidney injury (AKI) is a common and devastating complication of... 
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Impact of Acute Kidney Injury Following Diagnosis of Aggressive Lymphoma or Acute Leukemia on Long-Term Kidney Outcomes
by May, Heather Personett and Barreto, Erin F and Mara, Kristin C and McCullough, Kristen and Leung, Nelson and Habermann, Thomas M
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 1628 - 1628
Acute kidney injury (AKI) is common in those with newly diagnosed hematologic malignancies. Precipitants of AKI in this population may include tumor lysis... 
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Genetic Risk Factors for Cardiovascular Disease in Adult Lymphoma Patients
by Chen, Sunnia T and Boddicker, Nicholas J and Maurer, Matthew J and Allmer, Cristine and Robinson, Dennis P and Nowakowski, Grzegorz and Habermann, Thomas M and Slager, Susan L and Thompson, Carrie A and Cerhan, James R
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 5215 - 5215
Purpose The development of cardiovascular disease (CVD) is a relatively rare but a clinically important adverse event in the treatment of lymphoma,... 
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Relapses after Achieving EFS24 in Patients with Diffuse Large B-Cell Lymphoma in the Rituximab Era
by Wang, Yucai and Farooq, Umar and Link, Brian K and Hefazi, Mehrdad and Allmer, Cristine and Maurer, Matthew J and Witzig, Thomas E and Habermann, Thomas M and Ansell, Stephen M and Cerhan, James R and Nowakowski, Grzegorz S
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 454 - 454
Abstract Introduction: The addition of Rituximab to chemotherapy has significantly improved the outcome of patients with newly diagnosed diffuse large B-cell... 
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Lenalidomide in Combination with Standard R-CHOP Overcomes the Negative Prognostic Value of Peripheral Blood Absolute Lymphocyte/Monocyte Ratio at Diagnosis and during Treatment in Patients with Diffuse Large B-Cell Lymphoma
by Castellino, Alessia and Pederson, Levy D and Ristow, Kay M and Stenzel, Christina and Laplant, Betsy and Witzig, Thomas E and Habermann, Thomas M and Nowakowski, Grzegorz S and Porrata, Luis
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 4139 - 4139
Abstract Introduction. The peripheral blood absolute lymphocyte (ALC)/monocyte (AMC) ratio (ALC/AMC), as a surrogate of host immunity (i.e. ALC) and tumor... 
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Revised-MALT-IPI: A New Predictive Model That Identifies High-Risk Patients with Extranodal Marginal Zone Lymphoma (EMZL)
by Alderuccio, Juan Pablo and Reis, Isildinha M and Habermann, Thomas M and Link, Brian K and Thieblemont, Catherine and Conconi, Annarita and Larson, Melissa C and Cascione, Luciano and Zhao, Wei and Cerhan, James R and Zucca, Emanuele and Lossos, Izidore S
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 4010 - 4010
INTRODUCTION: EMZL is a heterogeneous disease with variable risk for relapse and progression. Based on age ≥70 years, stage III-IV and elevated LDH,... 
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text Cryptococcus neoformansinfections in patients with lymphoproliferative neoplasms
by Dioverti, Maria V and Parikh, Sameer A and Osmon, Douglas R and Habermann, Thomas M and Tande, Aaron J
Leukemia & Lymphoma, ISSN 1042-8194, 03/2019, Volume 60, Issue 4, pp. 920 - 926
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text Bleomycin use in the treatment of Hodgkin lymphoma (HL): toxicity and outcomes in the modern era
by Taparra, Kekoa and Liu, Heshan and Polley, Mei-Yin and Ristow, Kay and Habermann, Thomas M and Ansell, Stephen M
Leukemia & lymphoma, ISSN 1042-8194, 09/2019, pp. 1 - 11
One-in-five Hodgkin Lymphoma (HL) patients treated with bleomycin develop bleomycin pulmonary toxicity (BPT). Given bleomycin-omission data with negative... 
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
16. Full Text High Level MYC Amplification in Aggressive B-Cell Lymphomas: Is It a Marker of Aggressive Disease?
by Pophali, Priyanka and Marinelli, Lisa M and Ketterling, Rhett P and Meyer, Reid Gregory and McPhail, Ellen D and Kurtin, Paul J and Habermann, Thomas M and King, Rebecca L
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 1693 - 1693
Abstract MYC amplification (amp) is a marker of poor prognosis in many non-hematologic malignancies. While MYC translocations in B cell lymphoma (BCL) have... 
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
17. Full Text Prognostic Impact of Morphology, MYC Gene Partner and BCL2/BCL6 Translocation Status in "High Grade B-Cell Lymphomas with MYC and BCL2 and/or BCL6 Rearrangements"
by McPhail, Ellen D and Maurer, Matthew J and Ketterling, Rhett P and Macon, William R and Feldman, Andrew L and Kurtin, Paul J and Witzig, Thomas E and Vaidya, Rakhee and Habermann, Thomas M
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 1750 - 1750
Abstract Introduction: "High grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements" (HG DH/THL) is a new diagnosis per the revised 2016 WHO... 
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
18. Full Text Post-Transplantation Lymphoproliferative Disorders in Adults
by Dierickx, Daan and Habermann, Thomas M
The New England Journal of Medicine, ISSN 0028-4793, 02/2018, Volume 378, Issue 6, pp. 549 - 562
Solid-organ and hematopoietic stem-cell transplants are widely used for various life-threatening medical disorders. Prophylaxis against transplant rejection... 
SOLID-ORGAN TRANSPLANTATION | VIRAL LOAD | WHOLE-BLOOD | MEDICINE, GENERAL & INTERNAL | B-CELL LYMPHOMA | RISK-FACTORS | KIDNEY-TRANSPLANTATION | INITIAL THERAPY | EBV | EPSTEIN-BARR-VIRUS | BLOOD MONONUCLEAR-CELLS | Care and treatment | Lymphoproliferative disorders | Research | Diagnosis | Epidemiology | Risk factors | Graft-versus-host reaction | Transplants & implants | Hematology | Pathogenesis | Prophylaxis | Immunoproliferative diseases | Infections | Transplantation | Patients | Hemopoiesis | Graft rejection | Immunosuppression | Lymphocytes | Lymphomas | Health risk assessment
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
19. Full Text Lymphocyte-to-Monocyte Ratio at Diagnosis and Survival in De Novo Double/Triple Hit Diffuse Large B-Cell Lymphoma
by Porrata, Luis and Ristow, Kay and McPhail, Ellen D and Macon, William and Maurer, Matthew J and Nowakowski, Grzegorz S and Ansell, Stephen and Witzig, Thomas E and Markovic, Svetomir and Habermann, Thomas M
Blood, ISSN 0006-4971, 12/2015, Volume 126, Issue 23, pp. 3885 - 3885
Abstract The lymphocyte-to-monocyte ratio at diagnosis (LMR-D) has been reported to be a prognostic factor for clinical outcomes in both T-cell and B-cell... 
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
20. Full Text Long-term analysis of phase II studies of single-agent lenalidomide in relapsed/refractory mantle cell lymphoma
: BUCKSTEIN et al
by Witzig, Thomas E and Luigi Zinzani, Pier and Habermann, Thomas M and Tuscano, Joseph M and Drach, Johannes and Ramchandren, Radhakrishnan and Kalayoglu Besisik, Sevgi and Takeshita, Kenichi and Casadebaig Bravo, Marie-Laure and Zhang, Lei and Fu, Tommy and Goy, Andre
American Journal of Hematology, ISSN 0361-8609, 10/2017, Volume 92, Issue 10, pp. E575 - E583
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.